Key result
Administration of Ginsenoside Rg1 to high-fat diet-induced obese mice significantly decreased body weight, total cholesterol, and total triglyceride levels via AMPK activation.
Ginsenoside Rg1 demonstrates anti-obesity and anti-adipogenic effects in preclinical models mediated by AMPK activation.
Rg1 attenuates HFD-induced obesity in mice; leaves open human cardiometabolic translation pending trials.
Ginsenosides Rg1 is one of the major pharmacologically active saponins in ginseng, which as an antioxidant reduces oxidative damage in the liver and can also be used to prevent cardiovascular diseases and diabetes. However, there is no research targeting the effect of lipid metabolism in high-fat diet (HFD)-induced mice. In this study, we evaluated the anti-obesity effects of Rg1 in 3T3-L1 adipocyte cells and HFD-induced obese C57BL/6J mice. Administration of Rg1 to HFD-induced obese mice significantly decreased body weight, total cholesterol, and total triglyceride levels. In addition to effects in 3T3-L1 cells, Rg1 reduced the accumulation of lipid droplets in a dose-dependent manner. Furthermore, Rg1 exhibits an anti-adipogenic effect via regulation of the expression of the transcriptional factors and lipid metabolism-related genes in vivo and in vitro. We observed that Rg1 administration significantly increased the phosphorylation level of AMP-activated protein kinase (AMPK) in both epididymal white adipose tissue and 3T3-L1 cells. These results indicated that Rg1 works both in an anti-adipogenic and anti-obesity manner through inducing AMPK activation, inhibiting lipogenesis, and decreasing intracellular lipid content, adipocyte size, and adipose weight.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) studied Obesity. Ginsenoside Rg1 was evaluated on Body weight, total cholesterol, total triglyceride levels, and lipid droplet accumulation. Administration of Ginsenoside Rg1 to high-fat diet-induced obese mice significantly decreased body weight, total cholesterol, and total triglyceride levels via AMPK activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: